Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Polyus reported for 2024 by RAS
Yesterday at 10:51
PLZL
MTS reports for 2024 by IFRS
Yesterday at 10:48
MTSS
MTS Bank reported for 2024 by IFRS
Yesterday at 10:41
MBNK
HeadHunter reports for 2024 by IFRS
Yesterday at 10:29
HEAD
Polyus updated its dividend policy
Yesterday at 10:25
PLZL
Polyus increased gold production and sales in 2024
Yesterday at 10:11
PLZL
Polyus reported for 2024 by IFRS
Yesterday at 09:49
PLZL
JetLend will begin collecting IPO filings on March 12
Yesterday at 09:01
JTLD
Digital Habits Group completed Pre-IPO
3/4/25
OTCI
SPB Exchange admitted JetLend shares to trading
3/4/25
SPBE
«
Previous
1
2
3
4
5
6
7
8
9
10
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 